zb001
Generic: insulin-like growth factor-1 receptor ("IGF-1R") monoclonal antibody·Code: ZB001, VRDN-001
zb001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zenas BioPharma, Inc. (ZBIO) | Phase 1 |
Clinical Trials (1)
A Single Ascending Dose, Safety, and Pharmacokinetic Study of ZB001 in Healthy Chinese Subjects
Frequently asked questions
Who is developing zb001?
zb001 is being developed by Zenas BioPharma, Inc..
How many clinical trials involve zb001?
BioSniper tracks 1 clinical trial involving zb001.
Get deeper analysis on zb001
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis